Wanbury Share Price
Small Cap | Pharmaceuticals and health care | NSE: WANBURY | BSE: 524212
₹210.20 
6.30 (3.09 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 205.70
High (₹) 216.45
Low (₹) 202.00
Prev. Close (₹) 203.90
Volume 8,403
VWAP (₹) 170.88
ROCE (%) 46.34
Industry P/E 43.95
TTM P/E 15.69
P/B Ratio 24.67
Market Cap (₹) Cr.689.59
Dividend Yield (%)--
EPS (₹) 16.89
ROE198.01%
Sales Growth (%) 15.21
Profit Growth (%)-638.26
Day Range
216.45216.45
52 Week Range
122.10325.00
Historical Returns
Returns (6M)
-16.92 %
Returns (1Y)
64.09 %
Returns (3Y)
154.79 %
Returns (5Y)
961.62 %
Returns (6M)
-16.92 %
Returns (1Y)
64.09 %
Returns (3Y)
154.79 %
Returns (5Y)
961.62 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 42.10
MFI 20.09
ATR 19.84
Commodity Channel Index -203.66
ROC125 -26.11
ROC21 -24.09
Williams %R -94.50
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 177.65 | 183.55 | 188.80 | 172.40 | 166.50 | 161.25 | 155.35 |
| Week Ago | 210.50 | 217.65 | 221.70 | 206.45 | 199.30 | 195.25 | 188.10 |
| Month Ago | 227.79 | 235.92 | 243.09 | 220.62 | 212.49 | 205.32 | 197.19 |
EMA & SMA
210.20
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
10
5 Day 193.32
9 Day 199.09
10 Day 201.17
12 Day 204.94
14 Day 208.71
20 Day 211.53
26 Day 215.78
50 Day 242.14
100 Day 244.84
200 Day 219.38
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED | bulk | Buy | 04 May, 2023 | ₹52.70 | 2,19,753 | BSE |
| RASHI FINCORP LIMITED | bulk | Sell | 21 Apr, 2023 | ₹38.00 | 1,96,000 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 17 May, 2024 | SBICAP Trustee Cumpany Limited | Pledge | ₹10.00 | 85,000 | BSE |
| 15 Apr, 2024 | SBICAP trustee Company Limited | Pledge | ₹10.00 | 7,40,743 | BSE |
| 22 Mar, 2024 | Expert Chemicals India Private Limited | Acquisition | ₹120.00 | 20,00,000 | BSE |
| 28 Aug, 2023 | SBICAP Trustee Company Limited | Pledge | ₹10.00 | 59,25,231 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 06 Mar, 2025 | BSE India | Disclosure under regulation 30 of SEBI (LODR) Regulations, 2015 Press Release on Refinancing of Outstanding Debentures |
| 06 Mar, 2025 | NSE India | Wanbury Limited has informed the Exchange regarding a press release dated March 06, 2025, titled ""Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 {""Listing Regulations'''')"". |
| 28 Feb, 2025 | BSE India | This is to inform that the Day to Day Affairs Committee (Constituted by the Board of Directors of Wanbury Limited) in its meeting held today have approved the allotment of 1750 having face Value of Rs. 1000000 amounting to 1750000000 Non-Convertible Debentures to Emerging India Credit Opporunities Fund II on Private Placement Basis. |
| 28 Feb, 2025 | NSE India | Wanbury Limited has informed the Exchange regarding allotment of 1750 securities pursuant to Preferential Issue at its meeting held on February 28, 2025 |
| 20 Feb, 2025 | BSE India | Submission of Voting Results of the EOGM |
| 20 Feb, 2025 | NSE India | WANBURY LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 20 Feb, 2025 | NSE India | Wanbury Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 20, 2025 |
| 20 Feb, 2025 | NSE India | Intimation under Regulation 30 and Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on appointment of Mr. Manojkumar Khubchand Gursahani (DIN: 01064558) and Mr. Pallavur Sankar Dass Vaidyanathan (DIN: 06604217) as the Non-Executive Independent Director of the Company. |
| 20 Feb, 2025 | BSE India | Appointment of Non-Executive Independent Directors. |
| 20 Feb, 2025 | BSE India | Appointment of Non-Executive Independent Directors in the Company. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | Inter-alia, to consider 1. The issue of senior, secured, unlisted redeemable and non- convertible debentures on private placement basis and other matters in relation to such issue. | 11 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 12 Aug, 2024 |
| Audited Results | -- | 08 May, 2024 | 16 May, 2024 |
| Quarterly Results | -- | 15 Jan, 2024 | 24 Jan, 2024 |
| Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. | 19 Oct, 2023 | 20 Oct, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 11 Aug, 2023 |
| Audited Results | (Revised) | 28 May, 2023 | 09 Jun, 2023 |
| Audited Results | -- | 28 May, 2023 | 30 May, 2023 |
| Quarterly Results | -- | 06 Feb, 2023 | 14 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Wanbury
Wanbury is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 575.65 Cr. and Equity Capital is Rs. 32.75 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1988
Managing Director
-- --
NSE Symbol
WANBURY
Wanbury Management
| Name | Designation |
|---|---|
| Mr. K Chandran | Vice Chairman & Whole Time Dir |
| Ms. Anupama Vaidya | Ind. Non-Executive Woman Director |
| Mr. Mohan Kumar Rayana | Whole Time Director |
| Mr. Pravin Dilip Pawar | Ind. Non-Executive Director |
| Mr. Mridul Sumanlal Mehta | Addnl.Non Exe.Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Wanbury
What is the share price of Wanbury?
The share price of Wanbury on 13 Mar, 2025 is ₹ 210.20.
What is 52W high and 52W low share price of Wanbury?
The highest and lowest 52W share prices of Wanbury are ₹ 325.000 and ₹ 122.100
What is the market cap of Wanbury?
The market capitalization of Wanbury as of 13 Mar, 2025 is ₹ 689.59 Crores
What is the P/E ratio of Wanbury?
The current P/E ratio of Wanbury as of 13 Mar, 2025 is 43.95
What is the PB ratio of Wanbury?
The PB ratio of Wanbury as of 13 Mar, 2025 is 24.67
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)